Dopamine depletion augments endogenous opioid-induced locomotion in the nucleus accumbens using both mu 1 and delta opioid receptors
- PMID: 8524983
- DOI: 10.1007/BF02311183
Dopamine depletion augments endogenous opioid-induced locomotion in the nucleus accumbens using both mu 1 and delta opioid receptors
Abstract
The aim of this study is to analyze further the opioid receptor subtypes involved in the augmentation of behavioral activity after dopamine depletion in the nucleus accumbens of rats. Initially, the opioid receptors involved in the augmentation of locomotion produced by endogenous opioids were evaluated by microinjection of kelatorphan, an inhibitor of proteolytic enzymes that inactivates enkephalin, with or without specific antagonists for mu 1 or delta-opioid receptors, naloxonazine or naltrindole, respectively. Kelatorphan produced a dose-dependent increase in horizontal photocell counts and vertical movements. At all doses examined the behavioral response was augmented in rats sustaining accumbal dopamine lesions. The augmentation in dopamine-depleted rats was partially blocked by naloxonazine or naltrindole. Since the motor stimulant response to intra-accumbens microinjection of the delta-opioid agonist, [D-penicillamine2,5]-enkephalin, was not augmented in a previous study, we tested the behavioral response to a new endogenous delta-opioid agonist, [D-Ala2] deltorphin I. The locomotor response to deltorphin was slightly augmented in dopamine-depleted rats. These data suggest that the augmentation in the motor response elicited by endogenous opioids after dopamine lesions in the nucleus accumbens involves both mu 1, and delta-opioid receptors.
Similar articles
-
Dopamine depletion produces augmented behavioral responses to a mu-, but not a delta-opioid receptor agonist in the nucleus accumbens: lack of a role for receptor upregulation.Synapse. 1992 May;11(1):47-57. doi: 10.1002/syn.890110107. Synapse. 1992. PMID: 1318584
-
Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mesolimbic mu- and delta-2-opioid receptors.Neuroscience. 1999;92(4):1357-65. doi: 10.1016/s0306-4522(99)00046-9. Neuroscience. 1999. PMID: 10426490
-
Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.Neuroscience. 2005;135(1):213-25. doi: 10.1016/j.neuroscience.2005.03.065. Neuroscience. 2005. PMID: 16111831
-
Mechanisms underlying δ- and μ-opioid receptor agonist-induced increases in extracellular dopamine level in the nucleus accumbens of freely moving rats.J Oral Sci. 2017;59(2):195-200. doi: 10.2334/josnusd.16-0874. J Oral Sci. 2017. PMID: 28637978 Review.
-
Nucleus accumbens and dopamine-mediated turning behavior of the rat: role of accumbal non-dopaminergic receptors.J Pharmacol Sci. 2012;120(3):152-64. doi: 10.1254/jphs.12r02cr. Epub 2012 Oct 10. J Pharmacol Sci. 2012. PMID: 23059952 Review.
Cited by
-
The anatomy of co-morbid neuropsychiatric disorders based on cortico-limbic synaptic interactions.Neurotox Res. 2006 Oct;10(2):65-85. doi: 10.1007/BF03033236. Neurotox Res. 2006. PMID: 17062369 Review.
-
Estradiol: a key biological substrate mediating the response to cocaine in female rats.Horm Behav. 2010 Jun;58(1):33-43. doi: 10.1016/j.yhbeh.2009.12.003. Epub 2009 Dec 21. Horm Behav. 2010. PMID: 20026119 Free PMC article. Review.
-
Pharmacological traits of delta opioid receptors: pitfalls or opportunities?Psychopharmacology (Berl). 2013 Jul;228(1):1-18. doi: 10.1007/s00213-013-3129-2. Epub 2013 May 7. Psychopharmacology (Berl). 2013. PMID: 23649885 Free PMC article. Review.
-
Involvement of the nucleus accumbens in stimulation of the immune response in rats after activation of opioid mu receptors with DAGO.Neurosci Behav Physiol. 2002 Sep-Oct;32(5):529-32. doi: 10.1023/a:1019815824348. Neurosci Behav Physiol. 2002. PMID: 12403006
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials